SIX1 and neoplasm: Downregulation of the endogenous SIX1 by shRNA in TPC-1 cells not only showed a trend of slowing down the tumor associated weight loss (Figure 7A), but also significantly reduced the volume as well as the weight of xenografted tumors (Figures 7B–D).